These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 7072583)

  • 1. Clinical transvenous cardioversion of recurrent life-threatening ventricular tachyarrhythmias: low energy synchronized cardioversion of ventricular tachycardia and termination of ventricular fibrillation in patients using a catheter electrode.
    Zipes DP; Jackman WM; Heger JJ; Chilson DA; Browne KF; Naccarelli GV; Rahilly GT; Prystowsky EN
    Am Heart J; 1982 May; 103(5):789-94. PubMed ID: 7072583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacy of dual electrode systems for endocardial cardioversion of ventricular tachycardia: a prospective randomized crossover trial.
    Saksena S; An H
    Am Heart J; 1990 Jan; 119(1):15-22. PubMed ID: 2404386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low energy transvenous cardioversion of short duration atrial tachyarrhythmias in humans using a single lead system.
    Heisel A; Jung J; Fries R; Stopp M; Sen S; Schieffer H; Ozbek C
    Pacing Clin Electrophysiol; 1997 Jan; 20(1 Pt 1):65-71. PubMed ID: 9121973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transvenous cardioversion for the management of recurrent ventricular arrhythmias.
    Bucknall CA; Lewis S; Vincent R; Jackson G; Jewitt DE; Chamberlain DA
    Br Heart J; 1987 Sep; 58(3):245-50. PubMed ID: 3663424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective evaluation of single and dual current pathways for transvenous cardioversion in rapid ventricular tachycardia.
    Saksena S; Calvo RA; Pantopoulos D; Gadhoke A; Rothbart ST
    Pacing Clin Electrophysiol; 1987 Sep; 10(5):1130-41. PubMed ID: 2444937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective randomized study of the clinical efficacy and safety of transvenous cardioversion for termination of ventricular tachycardia.
    Ciccone JM; Saksena S; Shah Y; Pantopoulos D
    Circulation; 1985 Mar; 71(3):571-8. PubMed ID: 3971528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of ventricular tachycardia termination and acceleration during transvenous cardioversion as determined by cardiac mapping in man.
    Saksena S; Pantopoulos D; Hussain SM; Gielchinsky I
    Am Heart J; 1987 Jun; 113(6):1495-506. PubMed ID: 3591617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective evaluation of a sequential pacing and high-energy bidirectional shock algorithm for transvenous cardioversion in patients with ventricular tachycardia.
    Lindsay BD; Saksena S; Rothbart ST; Wasty N; Pantopoulos D
    Circulation; 1987 Sep; 76(3):601-9. PubMed ID: 3621521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventricular proarrhythmic effects of ventricular cycle length and shock strength in a sheep model of transvenous atrial defibrillation.
    Ayers GM; Alferness CA; Ilina M; Wagner DO; Sirokman WA; Adams JM; Griffin JC
    Circulation; 1994 Jan; 89(1):413-22. PubMed ID: 8281677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential transvenous pacing and shock therapy for termination of sustained ventricular tachycardia.
    Calvo RA; Saksena S; Pantopoulos D
    Am Heart J; 1988 Mar; 115(3):569-75. PubMed ID: 3344658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventricular tachycardia rate and morphology determine energy and current requirements for transthoracic cardioversion.
    Kerber RE; Kienzle MG; Olshansky B; Waldo AL; Wilber D; Carlson MD; Aschoff AM; Birger S; Fugatt L; Walsh S
    Circulation; 1992 Jan; 85(1):158-63. PubMed ID: 1728445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of transvenous low energy cardioversion of atrial fibrillation in patients with a history of ventricular tachycardia: effects of rate and repolarization time on proarrhythmic risk.
    Simons GR; Newby KH; Kearney MM; Brandon MJ; Natale A
    Pacing Clin Electrophysiol; 1998 Feb; 21(2):430-7. PubMed ID: 9507545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of shock timing on efficacy and safety of internal cardioversion for ventricular tachycardia.
    Li HG; Yee R; Mehra R; DeGroot P; Klein GJ; Zardini M; Thakur RK; Morillo CA
    J Am Coll Cardiol; 1994 Sep; 24(3):703-8. PubMed ID: 8077542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sustained ventricular tachycardia: low-energy transcatheter internal cardioversion. Efficacy, reliability and tolerance in comparison with ventricular burst].
    Vergara G; Disertori M; Inama G; Guarnerio M; Stirpe E; Furlanello F
    G Ital Cardiol; 1985 Sep; 15(9):862-72. PubMed ID: 4085732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants.
    Fromer M; Brachmann J; Block M; Siebels J; Hoffmann E; Almendral J; Ohm OJ; den Dulk K; Coumel P; Camm AJ
    Circulation; 1992 Aug; 86(2):363-74. PubMed ID: 1638705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocardial pacing, cardioversion and defibrillation using a braided endocardial lead system.
    Saksena S; Luceri R; Krol RB; Brownstein S; Burkhardt E; Accorti P; Brewer G; Scott S; Callaghan F; Livingston A
    Am J Cardiol; 1993 Apr; 71(10):834-41. PubMed ID: 8456763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Low energy cardioversion with the implantable cardioversion defibrillator devices for treatment of ventricular tachycardia and ventricular fibrillation].
    Siebels J; Schneider MA; Kuck KH
    Z Kardiol; 1993 Nov; 82(11):683-91. PubMed ID: 8291289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combined anti-bradycardia/anti-tachycardia pacemaker-cardioverter-defibrillator systems in patients with recurrent ventricular tachyarrhythmias].
    Schmitt C; Brachmann J; Saggau W; Beyer T; Waldecker B; Scharowski K; Hilbel T; Montero M; Offner B; Schöls W
    Z Kardiol; 1991 Nov; 80(11):665-72. PubMed ID: 1792808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Internal transvenous low energy cardioversion for the treatment of cardiac arrhythmias.
    Nathan AW; Bexton RS; Spurrell RA; Camm AJ
    Br Heart J; 1984 Oct; 52(4):377-84. PubMed ID: 6477776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporary transvenous cardioversion and defibrillation: a new method for practical tachyarrhythmia management.
    Luceri RM; Accorti PR
    Pacing Clin Electrophysiol; 1997 Jan; 20(1 Pt 2):168-72. PubMed ID: 9121983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.